Disability Diagnostics: Cancer

Cancer is the second leading cause of death in the US. In 2021, the American Cancer Society estimates 1.9 billion new cancer cases and over 600,000 cancer deaths will occur. This poses an enormous emotional, physical, and financial strain on individuals, business, and the global society. This snapshot provided by IBI's Disability Diagnosis Analyzer estimates [...]

Webinar September 9: Closing the Gap on Preventive Screenings

IBI Researcher Erin Peterson, MPH shared the latest IBI research on the gaps in preventive screenings for chronic conditions and cancers, highlighting employee health and productivity opportunities for improvement. Erin and IBI President Kelly McDevitt were joined by Kathleen Herath, former Associate Vice President of Wellbeing & Safety and discussed what Nationwide has learned from [...]

Closing the Gap: The Business Value of Preventive Screenings

Screenings for serious health conditions save lives, reduce treatment recovery times, and lower healthcare costs. They may also improve workplace productivity if early detection helps avoid disability leaves. Unfortunately, screening gaps exist for several conditions with well-known recommendations. The COVID-19 pandemic has created additional barriers for screening to recommended guidelines. To illustrate the potential productivity [...]

Disability Diagnosis Analyzer

IBI's Disability Diagnosis Analyzer uses short-term disability (STD) and long-term disability (LTD) claims from its Disability and Leave Benchmarking system to illustrate the disability burden of illnesses, diseases, injuries and pregnancies. We project the total number of disability incidents for the U.S. workforce covered for employer-based STD benefits. We then project the total costs of [...]

Benchmarking Analytics: Disability Leaves for Five Common Types of Cancer

A member brought to IBI’s attention a January 2018 Health Affairs report detailing the San Francisco Cancer Initiative's (SFCI) efforts to reduce the burden of five common cancers—breast, lung, prostate, colorectal, and liver—for which there are proven methods of prevention and detection, and for which effective treatments are known. The initiative can serve as a [...]

Go to Top